Carisbamate Treatment of Adult and Pediatric Patients With Lennox-Gastaut Syndrome: A Phase I Pharmacokinetic Dose-Escalation Study (P9-9.007)
Assess, in a phase 1, open-label study, pharmacokinetics (PK), safety, and tolerability of single-dose (SD) and multiple-dose (MD) adjunctive carisbamate in patients ≥2 years old with Lennox-Gastaut syndrome (LGS).
Authors
- David G. Vossler (ORCID: https://orcid.org/0000-0003-4823-0537)
- Vijay Vashi
Institutions
- University of Washington (US)
- SK Life Science (United States) (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000208551
- Citations
- 2
- Primary Topic
- Ion Transport and Channel Regulation
- Type
- article
- Field-Weighted Citation Impact
- 1.61